HL: Effectiveness of Health Literacy Education

Sponsor
Ayşegül Akca (Other)
Overall Status
Completed
CT.gov ID
NCT04868487
Collaborator
(none)
206
1
2
5.4
38

Study Details

Study Description

Brief Summary

To determine the effect of health literacy education given to nursing students. The study was conducted at two university nursing departments in Turkey between December 2018 and March 2019. A total of 206 nursing students, 103 in the intervention and 103 in the control group, were included in the study. Health literacy education, consisting of four sessions, was given to the intervention group.

Condition or Disease Intervention/Treatment Phase
  • Other: Health Literacy Education
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
206 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Effectiveness of Health Literacy Education for Nursing Students in Turkey
Actual Study Start Date :
Dec 1, 2018
Actual Primary Completion Date :
Mar 31, 2019
Actual Study Completion Date :
May 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention

The intervention group received four weekly training sessions of health literacy education. Each educational session lasted an average of 50 minutes. The students were divided into four groups with an average of 25 students in each group.

Other: Health Literacy Education
Health literacy education, consisting of four sessions, was given to the intervention group.

No Intervention: Control

The control group had no educational interaction with the researcher after the pre-test. The control group was administered the one-week and three-month posttest THLS-32 by the researcher simultaneously with the intervention group.

Outcome Measures

Primary Outcome Measures

  1. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [before the implementation]

    The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy. The health literacy level of the students was determined and the intervention and control group was selected from among the students with insufficient and problematic-limited health literacy level.

  2. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [one week after the implementation]

    The health literacy levels of the students who received and did not receive the intervention were compared. The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy.

  3. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [three months after the implementation.]

    The health literacy levels of the students who received and did not receive the intervention were compared. The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 32 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Inadequate (0-25 points) health literacy level

  • Problematic-limited (25-33 points) health literacy level

  • Accepting to participate in the research

  • Accepting to participate in the research

Exclusion Criteria:
  • Adequate (33-42 points) health literacy level

  • Excellent (42-50 points) health literacy level

  • Foreign language students with limited language proficiency

  • Visual-hearing disability

  • Having a neuropsychiatric disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ankara Yıldırım Beyazıt University Ankara Çubuk Turkey 06760

Sponsors and Collaborators

  • Ayşegül Akca

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ayşegül Akca, Research Assistant, Ankara Yildirim Beyazıt University
ClinicalTrials.gov Identifier:
NCT04868487
Other Study ID Numbers:
  • 2018-455
First Posted:
May 3, 2021
Last Update Posted:
May 6, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayşegül Akca, Research Assistant, Ankara Yildirim Beyazıt University

Study Results

No Results Posted as of May 6, 2021